Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.

P E Hutchinson(Leicester Royal Infirmary), Anthony A. Fryer(University of Staffordshire), John T. Lear(Royal Stoke University Hospital), Pasteur Bowers, Andrew G. Smith, Peter M. Jones, Pulliam Morris, R C Strange(Royal Stoke University Hospital), J.E. Osborne, corrispondente da New York
PubMed
February 1, 2000
Cited by 181


Related Papers

Preeclampsia and Future Cardiovascular Health
|Circulation Cardiovascular Quality and Outcomes|2017|1.1k
Non-melanoma skin cancer
|The Lancet|2010|874
Glutathione-S-transferase family of enzymes
|Mutation research. Fundamental and molecular mechanisms of mutagenesis|2001|831